Oncogenex Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Oncogenex Pharmaceuticals Inc
CIK #0000949858
EDGAR Form CIK 2011 - 2026
10-K [0000949858]
10-Q [0000949858]
3 [0000949858]
4 [0000949858]
5 [0000949858]
8-K [0000949858]
D [0000949858]
SC 13D [0000949858]
SC 13G [0000949858]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vivo Opportunity Fund Holdings LP Achieve Life Sciences Inc [2026-07-08]
venBio Global Strategic Fund V LP Achieve Life Sciences Inc [2026-04-27]
TPG GP A LLC Achieve Life Sciences Inc [2026-04-24]
Paradigm Biocapital Advisors LP Achieve Life Sciences Inc [2026-04-24]
Frazier Life Sciences Public Fund LP Achieve Life Sciences Inc [2026-04-24]
Venrock Healthcare Capital Partners III LP Achieve Life Sciences Inc [2026-04-24]
Alyeska Investment Group LP Achieve Life Sciences Inc [2025-08-14]
Vanguard Group Inc Achieve Life Sciences Inc [2024-11-04]
BlackRock Inc Achieve Life Sciences Inc [2024-10-25]
Propel Bio Management LLC Achieve Life Sciences Inc [2024-05-17]
View All
Form 3/4/5 Subject 2011 - 2026
Achieve Life Sciences Inc
Farrow Jeffrey S
Waldman Reid Alexander
Martin Christopher Nathan
Royston Aaron
Iancovici Lucian
TPG GP A LLC
Winkelried Jon
Coulter James G
Goldberg Andrew D
Xinos Jaime
Donnelly Craig
Rubinstein Mark Lawrence
Oki Mark K
Stewart Richard Alistair
Wan Jerry
Atkisson Erik
Martell Bridget A
Sellig Thomas
Duty Stuart
Slaoui Kristen B
Phelan Nancy R
King Thomas Braxton
Jacobs Cindy
Bencich John
Himes Vaughn B
SVB Innovation Credit Partners VIII-A LLC
Innovation Credit Fund VIII-A LP
SVB Innovation Credit Fund VIII LP
SVB Financial Group
SVB Innovation Credit Partners VIII LLC
Dialectic Life Sciences SPV LLC
Fichthorn John
Dialectic LS Manager LLC
Dialectic Capital Management LP
Dialectic Partners LLC
Moyes Jay M
Joseph Donald
Mattingly Martin A
Clarke Anthony
Cormack Scott Daniel
Parker H Stewart
Armistice Capital Master Fund Ltd
Boyd Steven
Armistice Capital LLC
Schacter Robert
Clendeninn Neil James
Smith David V
Goldstein Jack
Wyrick Susan D
Griffin Michelle Renee
Lawrence Cameron William
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2026-01-28 Grant 180,000 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2026-01-28 Grant 180,000 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2026-01-28 Grant 180,000 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2026-01-28 Grant 70,300 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2026-01-28 Grant 180,000 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2026-01-28 Grant 645,000 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2025-12-04 Grant 250,000 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2025-10-01 Grant 50,000 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2025-06-06 Grant 31,500 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2025-06-06 Grant 31,500 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2025-06-06 Grant 31,500 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2025-06-06 Grant 31,500 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2025-06-06 Grant 31,500 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2025-06-06 Grant 31,500 $0.00
Achieve Life Sciences Inc ACHV
Common Stock
2025-03-17 Buy 10,000 $2.86 28,600
Achieve Life Sciences Inc ACHV
Common Stock
2025-03-17 Buy 10,000 $2.89 28,900
Achieve Life Sciences Inc ACHV
Performance Restricted Stock Unit (PRSU) · derivative
2025-01-28 Grant 48,000 $0.00
Achieve Life Sciences Inc ACHV
Performance Restricted Stock Unit (PRSU) · derivative
2025-01-28 Grant 130,000 $0.00
Achieve Life Sciences Inc ACHV
Performance Restricted Stock Unit (PRSU) · derivative
2025-01-28 Grant 100,000 $0.00
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
2025-01-13 Grant 47,250 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com